Trevor James
The US military has a history of administering vaccines to service members, and in 1998, the Anthrax Vaccine Immunization Program (AVIP) was set up by the Clinton administration to immunize military personnel with BioThrax, an anthrax vaccine. While the exact dates of its administration are unclear, the licensed anthrax vaccine, AVA, was routinely given to US workers with exposure to anthrax spores, and it is estimated that 68,000 doses were distributed between 1974 and 1989. With concerns about anthrax being used as a biological weapon, the US military has continued to require various vaccinations for its members, including smallpox and Japanese encephalitis.
| Characteristics | Values |
|---|---|
| Year | 1989 |
| Number of doses of the U.S. anthrax vaccine distributed | 68,000 |
| Total number of doses distributed from 1974 to 1989 | 68,000 |
| Total number of doses distributed in 1990 | 268,000 |
| Total number of doses distributed from 1991 to July 1999 | 1.2 million |
| Year the Anthrax Vaccine Immunization Program (AVIP) began | 1998 |
| Year the safety of the anthrax vaccine was questioned | 2004 |
| Year the Anthrax Vaccine Immunization Program was halted | 2001 |
Explore related products
![The Enigma Years (1987-1990) Capacity Wallet]](https://m.media-amazon.com/images/I/91IiU4h1a+L._AC_UY218_.jpg)
What You'll Learn
The Anthrax Vaccine Immunization Program (AVIP)
The vaccination requirement was instituted due to concerns that anthrax could be used as a biological weapon. Anthrax had previously been used in warfare as early as World War I, and there were concerns that Iraq had biological weapons containing anthrax spores during the Gulf War. The Japanese doomsday cult Aum Shinrikyo also carried out an unsuccessful anthrax attack in 1993, and Iraq was found to have a biological weapons program that included anthrax in 1995.
The AVIP began in March 1998, with nearly 8 million doses of BioThrax administered to over 2 million individuals between March 1998 and December 2008. The program was halted in June 2001 due to changes in the manufacturing process that were not approved by the Food and Drug Administration (FDA). However, following the 2001 anthrax attacks and the 2003 invasion of Iraq, all military personnel were required to receive the anthrax vaccine.
The AVIP has faced legal challenges, with some service members refusing the vaccine due to concerns about its safety and efficacy. In 2006, a class-action lawsuit was filed on behalf of six unnamed plaintiffs, claiming that the vaccine was "unapproved for its applied/intended use" and that it had not been properly approved by the government. The AVIP has also faced supply issues, with a limited supply of AVA slowing down plans to vaccinate all military personnel by 2001.
IPV Vaccines: Availability at the Bureau of Quarantine
You may want to see also
Explore related products
The safety of the vaccine
The safety of the anthrax vaccine has been a topic of discussion and study for several years. The vaccine is made by taking a strain of the bacterium, Bacillus anthracis, and growing it in a laboratory. The bacteria release harmful toxins, which are then inactivated with formaldehyde. The anthrax bacteria are then filtered out of the vaccine.
In 1985, an FDA advisory panel categorized the anthrax vaccine as Category 1 (safe, effective, and not misbranded). The effectiveness of the vaccine was studied to be about 92%. At least 95 out of 100 people given at least two doses of the vaccine will develop high levels of antibodies against anthrax.
However, there have been concerns and reports of adverse effects. Mild side effects include pain, redness, and swelling at the site of the vaccine, which occurs in about 10% of people. About 1% of people given the vaccine will develop severe pain and swelling. Other short-term side effects include fever, chills, body aches, and nausea, which occur in about four out of every 7,000 people.
There have also been concerns about the potential link between the anthrax vaccine and Gulf War Syndrome (GWS). However, a study found no difference in the percentage of people with antibodies to anthrax between those who reported symptoms of GWS and those who did not, suggesting that the vaccine did not cause GWS.
The anthrax vaccine is currently recommended only for certain high-risk groups, including military personnel, lab personnel, and handlers of animals or animal products. The risk of exposure to anthrax for the general population in the United States is low.
US Immigration: Vaccination Requirements for Immigrants
You may want to see also
Explore related products
Concerns about anthrax as a biological weapon
Anthrax has been a concern as a biological weapon since the First World War, when it was used against livestock. During the Second World War, the United States, Canada, and Great Britain tested anthrax bombs on Gruinard Island, Scotland, killing 80 sheep. In 1932, Japan tested anthrax as a weapon by infecting prisoners in Manchuria as part of its biological weapons program.
In 1944, the US converted the Vigo Ordnance Plant, Indiana, to mass-produce biological agents for its bio-weapons program, intending to produce anthrax bombs on an industrial scale. The US also kept "cattle cakes" containing anthrax spores for possible retaliation against biological warfare by Nazi Germany.
In 1969, President Richard Nixon issued an executive order to terminate the United States' biological weapons program, leading to the destruction of the arsenal and the termination of research and production. This shift led to increased resources for developing vaccines, treatments, and diagnostic tests to defend against biological weapons.
Despite international disarmament agreements, the threat of biological warfare agents continues to exist. The largest anthrax epidemic in the last 200 years occurred in Rhodesia (now Zimbabwe) in the 1980s, with possible evidence of deliberate releases by Rhodesian and South African forces.
After the 9/11 attacks and the subsequent 10 cases of inhalational anthrax, concerns were raised that these attacks marked the beginning of a new era of terrorism. In 2001, letters containing powdered anthrax spores were mailed in the United States, causing 22 infections and 5 deaths.
The CDC has classified Bacillus anthracis as a Category A organism, which is easily disseminated and/or transmitted from person to person, resulting in high mortality rates. Anthrax is particularly suitable as a biological weapon because it can cause widespread illness and death and potentially cripple a city or region.
To prepare for a possible anthrax attack, the CDC promotes preparedness and response activities, ensuring that the United States has enough laboratories to conduct rapid tests. The CDC also works with hospitals, laboratories, emergency response teams, and healthcare providers to ensure they have the necessary medicine and supplies.
The Anthrax Vaccine Immunization Program (AVIP) was established to immunize US military personnel and certain civilians with BioThrax, an anthrax vaccine. Between 1974 and 1989, 68,000 doses of the US anthrax vaccine were distributed, and over 300,000 doses were administered during the Gulf War.
Vaccine Side Effects: Muscle Spasms Explained
You may want to see also
Explore related products
The use of vaccines in the Gulf War
The Gulf War, which took place during the early 1990s, saw the use of various vaccines to protect troops from biological warfare agents. There were concerns before the war regarding Iraq's biological warfare capabilities, leading to the decision to utilise available vaccines as a preventive measure.
The Anthrax Vaccine Immunization Program (AVIP) was set up by the Clinton Administration to immunise military personnel and certain civilians with BioThrax, an anthrax vaccine. It is estimated that 310,680 doses of the anthrax vaccine were distributed during the Gulf War, with 150,000 US troops receiving at least one vaccination. The anthrax vaccine had been routinely administered to US workers with occupational exposure to anthrax, and at the time of the Gulf War, there were fears that Iraq had produced weapons containing anthrax spores.
In addition to the anthrax vaccine, other immunobiologics were also used during the Gulf War, including cholera, meningitis, rabies, tetanus, and typhoid vaccines. The US military also has a standard set of vaccinations required for each military recruit, which varies slightly by branch of service. Certain vaccines were also recommended for personnel deploying to specific regions, such as the Southwest Asian theatre of the Gulf War. For example, the meningococcal vaccine was given to all recruits during initial training to prevent meningococcal diseases, and the plague vaccine was given to Marine Corps recruits and selected special operating forces.
The safety of the anthrax vaccine has been a subject of discussion, with the Institute of Medicine's Committee on Health Effects Associated with Exposures During the Gulf War concluding that there is insufficient evidence to determine the association between multiple vaccinations and long-term adverse health problems. However, the Brachman study and other early experimental studies found transient local and systemic effects, primarily erythema, edema, and induration.
Polio Vaccine: Bug-Free or Not?
You may want to see also
Explore related products
The legality of mandatory inoculations
The debate surrounding mandatory inoculations is complex and multifaceted, involving ethical, legal, and public health considerations. While some countries and jurisdictions have imposed mandatory vaccination requirements, particularly for specific sectors such as healthcare and education, others have relied on incentives and educational campaigns to encourage voluntary vaccination.
In the context of the 1989 anthrax vaccine administration by the USAF, it is important to understand the legal framework and justifications surrounding mandatory inoculations. The US military has a longstanding tradition of mandating various vaccines for service members to protect them from potential disease risks, especially in the context of biological warfare concerns. The Anthrax Vaccine Immunization Program (AVIP) was instituted in 1998 due to fears of anthrax being used as a biological weapon, and it was considered a lawful order for military personnel to receive the vaccine.
In the United States, the legality of mandatory vaccination has been upheld by the US Supreme Court, which stated that during a pandemic, the state's interest in protecting society can supersede an individual's right to liberty. This precedent sets a significant framework for justifying mandatory vaccination requirements, especially in critical sectors. Additionally, employers in the US have been granted the authority to mandate immunizations for their employees, as seen in the case of flu vaccines.
The debate surrounding mandatory inoculations often centres on the rights of the community versus those of the individual. While achieving herd immunity and protecting public health are compelling reasons for mandatory vaccination, legal compulsion can impinge on a parent's right to choose what they believe is in the best interest of their child. This dilemma underscores the complexity of the issue, highlighting the need for careful consideration and stakeholder engagement when formulating public health policies related to mandatory inoculations.
Creating a Vaccine: Ellie's Story and Potential
You may want to see also
Frequently asked questions
Yes, the USAF administered the anthrax vaccine in 1989.
The Anthrax Vaccine Immunization Program (AVIP) was the name of the policy set forth by the Clinton administration to immunize military and certain civilian personnel.
No, the anthrax vaccine was never proven to be safe and effective. It is considered to be one cause of Gulf War illnesses, and recent vaccinees have reported similar symptoms.
The symptoms included fever, erythema, induration, and soreness.
Yes, vaccination was mandatory and those who refused were prosecuted. However, in 2004, mandatory vaccinations were halted by a formal legal injunction due to safety concerns.
